Invesco Health Care Fund Class A (GGHCX)
| Fund Assets | 1.23B |
| Expense Ratio | 1.06% |
| Min. Investment | $1,000 |
| Turnover | 59.00% |
| Dividend (ttm) | 2.20 |
| Dividend Yield | 5.73% |
| Dividend Growth | 20.01% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 18, 2025 |
| Previous Close | 36.35 |
| YTD Return | -5.37% |
| 1-Year Return | 5.51% |
| 5-Year Return | 16.83% |
| 52-Week Low | 33.82 |
| 52-Week High | 42.99 |
| Beta (5Y) | 0.71 |
| Holdings | 78 |
| Inception Date | Aug 7, 1989 |
About GGHCX
Invesco Health Care Fund Class A is an actively managed mutual fund designed to provide long-term capital growth by investing primarily in equity securities of global health care companies. The fund targets firms recognized as industry leaders and innovators, focusing on those with strong management and competitive advantages. By maintaining a portfolio diversified across sub-sectors such as pharmaceuticals, biotechnology, medical equipment, managed health care, and life sciences tools, the fund captures the dynamic growth potential of the health care industry. With over 70 holdings and a weighted average market capitalization in the large-cap range, the fund includes notable positions in companies like Boston Scientific, Eli Lilly, Stryker, and AbbVie. It invests across all market capitalizations and geographic regions, though it is predominantly U.S.-focused, with selective international exposure. By allocating at least 80% of assets to health care-related securities, Invesco Health Care Fund Class A plays a significant role for investors seeking targeted exposure to advancements and growth trends in global health care markets.
Performance
GGHCX had a total return of 5.51% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.76%.
Top 10 Holdings
44.66% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.55% |
| Boston Scientific Corporation | BSX | 5.10% |
| AbbVie Inc. | ABBV | 5.02% |
| Cencora, Inc. | COR | 4.73% |
| Gilead Sciences, Inc. | GILD | 3.89% |
| AstraZeneca PLC | AZN | 3.80% |
| argenx SE | ARGX | 3.62% |
| Johnson & Johnson | JNJ | 3.41% |
| McKesson Corporation | MCK | 3.21% |
| Thermo Fisher Scientific Inc. | TMO | 2.33% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $2.2025 | Dec 18, 2025 |
| Dec 16, 2024 | $1.8353 | Dec 16, 2024 |
| Dec 16, 2021 | $9.9297 | Dec 16, 2021 |
| Dec 15, 2020 | $0.4737 | Dec 15, 2020 |
| Dec 13, 2019 | $1.4728 | Dec 13, 2019 |
| Dec 14, 2018 | $2.9024 | Dec 14, 2018 |